» Articles » PMID: 9692547

Identification of PTEN/MMAC1 Alterations in Uncultured Melanomas and Melanoma Cell Lines

Overview
Journal Oncogene
Date 1998 Aug 6
PMID 9692547
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

A novel tumor suppressor gene, PTEN/MMAC1, has been recently shown to be mutated in gliomas, breast, prostate, kidney cancers and melanomas. Loss-of-heterozygosity studies in melanoma have suggested the presence of at least one chromosome 10q locus lost early in tumor progression. In this study, we screened 45 melanoma cell lines and 17 paired uncultured metastatic melanoma and peripheral blood specimens for PTEN/ MMAC1 alterations using PCR-SSCP and direct sequencing. We found nine melanoma cell lines with homozygous deletions (five with intragenic loss) and four cell lines with mutations (one nonsense and one frameshift; two intronic); from among our uncultured melanoma specimens, we found one tumor with a somatic 17 bp duplication in exon 7 leading to a premature stop codon and one tumor with a possible homozygous deletion. Furthermore, we have identified a novel intragenic polymorphism within intron 4 of PTEN/MMAC1. Taken together, these data suggest that PTEN/MMAC1 may be a chromosome 10q tumor suppressor important in melanoma tumor formation or progression.

Citing Articles

A Multimodal Drug-Diet-Immunotherapy Combination Restrains Melanoma Progression and Metastasis.

Oatman N, Gawali M, Congrove S, Caceres R, Sukumaran A, Gupta N Cancer Res. 2024; 84(14):2333-2351.

PMID: 38885087 PMC: 11250569. DOI: 10.1158/0008-5472.CAN-23-1635.


p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.

de Kort W, de Ruiter E, Haakma W, Driehuis E, Devriese L, van Es R Head Neck Pathol. 2023; 17(3):697-707.

PMID: 37486536 PMC: 10514008. DOI: 10.1007/s12105-023-01576-4.


Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance.

Wagstaff W, Mwamba R, Grullon K, Armstrong M, Zhao P, Hendren-Santiago B Genes Dis. 2022; 9(6):1608-1623.

PMID: 36157497 PMC: 9485270. DOI: 10.1016/j.gendis.2022.04.004.


Schweinfurthin induces ICD without ER stress and caspase activation.

Zhang R, Neighbors J, Schell T, Hohl R Oncoimmunology. 2022; 11(1):2104551.

PMID: 35936984 PMC: 9354771. DOI: 10.1080/2162402X.2022.2104551.


Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy.

Schmitt M, Sinnberg T, Niessner H, Forschner A, Garbe C, Macek B Cancers (Basel). 2021; 13(21).

PMID: 34771574 PMC: 8582461. DOI: 10.3390/cancers13215411.